Modulation of nitric oxide and cytokines production by L-arginine in human gut mucosa

Background: Arginine is a conditionally essential amino-acid with immuno-modulatory properties, mainly through the nitric oxide (NO) pathway. Aim: To assess the effects of arginine on intestinal production of pro- and anti-inflammatory cytokines and NO in human gut. Methods: An enteral solution of arginine or a control solution of amino-acids was administered to 8 healthy volunteers on a randomized cross-over design. Duodenal. biopsies were taken. Pro- (IL-6, IL-8) and anti-inflammatory (IL-4, IL-10) cytokines mRNA expression was assessed by RT-PCR. Other biopsies were cultured with 0.1, 0.5 or 2 mM arginine or control amino-acids, under basal or IL-1 beta-induced inflammatory conditions. Interleukin-4, IL-6, IL-8 and IL-10 production was measured in culture supernatant by ELISA and NO production by Griess reaction. Results: Arginine enhanced the production of NO under inflammatory conditions in a dose-dependent manner (P = 0.03). IL-1 beta increased the production of IL-8 and IL-6 (P < 0.01). Arginine had no effect on pro- and anti-inflammatory cytokines production both under basal and inflammatory conditions. Conclusions: Arginine enhanced the production of NO but did not affect that of cytokines in inflammatory human gut. Further clinical studies are required to assess whether arginine-enhanced NO production plays a beneficial or deleterious effect in intestinal inflammation. (c) 2004 Elsevier Ltd. All rights reserved.